Enzymatic decontamination technology for waste water ("Endetech")
Since 2012 ChiralVision participates in the EU funded project called "ENDETECH" (ENzymatic Decontamination TECHnology). The objective of this project program is to develop a technology which aims at eliminating persistent pharmaceutical pollutants in wastewaters originating from drug manufacturing sites, households, hospitals and animal farms, thanks to an innovative ENzymatic Decontamination TECHnology. The pharmaceutical pollutants targeted in priority during this project will be antibiotics, hormones & endocrine disruptors and anti-cancer drugs.
ChiralVision (the Netherlands) is working closely with 5 other partners originating from different countries: Da Volterra (France), c-LEcta and the Goethe Frankfurt University (Germany), the European Membrane Institute from the CNRS (France) and the Catalan Institute for Water Research (Spain).
The ENDETECH research project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°282818.
Visit the Endetech website